Keyphrases
Nuclear Translocation
100%
Cell Cycle Arrest
100%
Molecular Response
100%
Cyclin-dependent Kinase 4 (CDK4)
100%
Molecular Mechanism
66%
Bladder Cancer Cells
66%
Clinical Trials
33%
Therapeutic Efficacy
33%
Monotherapy
33%
RNA Sequencing (RNA-seq)
33%
Standard of Care
33%
Cancer Cells
33%
Apoptosis
33%
Treatment Regimen
33%
Protein Family
33%
Metastatic Breast Cancer
33%
Therapy Response
33%
Endocrine Therapy
33%
Response to Therapy
33%
Senescence
33%
Resistance Mechanisms
33%
Poor Response
33%
G1 Arrest
33%
SCF Complex
33%
Response Mechanism
33%
Importin
33%
Rb Protein
33%
Therapeutic Design
33%
CDK4/6 Inhibitor Palbociclib
33%
Lysosomal Biogenesis
33%
PD Treatment
33%
Gankyrin
33%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Cell Cycle Arrest
100%
Cell Cycle Checkpoint
100%
Clinical Trial
33%
Importin
33%
Protein Family
33%
RNA Sequence
33%
Biogenesis
33%
G1/S Transition
33%
SCF Complex
33%
Karyopherin
33%
Programmed Cell Death
33%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
100%
Endocrine Therapy
50%
Clinical Trial
50%
RNA-Sequencing
50%
Palbociclib
50%
Malignant Neoplasm
50%
Metastatic Breast Cancer
50%
Combination Therapy
50%
Monotherapy
50%
Karyopherin
50%